BC
AGN

Barnett & Company’s Allergan plc AGN Stock Holding History

Barnett & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-305
Closed -$54K – 381
2020
Q1 		$54K Hold
305
– – 0.05% 130
2019
Q4 		$58K Sell
305
-175
-36% -$31.6K 0.04% 158
2019
Q3 		$81K Sell
480
-3,523
-88% -$574K 0.05% 139
2019
Q2 		$670K Sell
4,003
-250
-6% -$34.6K 0.38% 60
2019
Q1 		$623K Sell
4,253
-20
-0.5% -$2.9K 0.36% 59
2018
Q4 		$571K Sell
4,273
-1,102
-21% -$181K 0.33% 58
2018
Q3 		$1.02M Sell
5,375
-105
-2% -$19.3K 0.47% 54
2018
Q2 		$914K Buy
5,480
+2,546
+87% +$409K 0.44% 55
2018
Q1 		$494K Sell
2,934
-65
-2% -$10.9K 0.25% 78
2017
Q4 		$491K Sell
2,999
-975
-25% -$175K 0.24% 88
2017
Q3 		$814K Buy
3,974
+5
+0.1% +$1.16K 0.41% 69
2017
Q2 		$965K Buy
3,969
+2,490
+168% +$585K 0.46% 69
2017
Q1 		$353K Buy
1,479
+270
+22% +$62.9K 0.19% 98
2016
Q4 		$254K Buy
1,209
+130
+12% +$26.9K 0.13% 120
2016
Q3 		$249K Buy
1,079
+50
+5% +$12.2K 0.13% 128
2016
Q2 		$238K Buy
1,029
+615
+149% +$142K 0.13% 128
2016
Q1 		$111K Buy
+414
New +$119K 0.06% 174

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Barnett & Company's AGN Position: Q2 2020 in Review

Barnett & Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 305 shares — an estimated $54K sold.

Barnett & Company first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $1.02M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Barnett & Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Barnett & Company sold 305 Allergan plc shares in Q2 2020, an estimated $54K.
  • Barnett & Company first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Barnett & Company's Allergan plc position peaked at $1.02M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Barnett & Company's 13F filing for Q2 2020, filed 22 Jul 2020.